Smith & Nephew plc is a global medical technology company specializing in the design, development and manufacture of advanced surgical devices, orthopaedic reconstruction implants, trauma and extremities products, sports medicine solutions and wound care therapies. Founded in 1856 in Hull, United Kingdom, the company has grown through both organic innovation and strategic acquisitions to offer a broad portfolio that addresses patient needs across joint replacement, minimally invasive surgery and wound healing.
In its orthopaedics business, Smith & Nephew provides hip and knee replacement systems, modular joint revision implants and biologic solutions for bone repair. Its sports medicine and ear, nose & throat (ENT) division develops arthroscopic visualization systems, shavers and biologic adjuncts to support minimally invasive procedures in joints and soft tissues. The company’s trauma and extremities segment offers a range of plates, nails and fixation devices for fracture management, while its advanced wound management arm markets negative pressure wound therapy systems, collagen dressings and antimicrobial solutions for chronic and acute wounds.
Headquartered in London and listed on both the London Stock Exchange and the New York Stock Exchange (NYSE: SNN), Smith & Nephew serves healthcare providers in more than 100 countries across Europe, North America, Latin America, Asia Pacific and the Middle East. Its global manufacturing footprint encompasses production sites in the United Kingdom, United States, Germany, Switzerland, Costa Rica and China, supported by research and development centers in key markets to drive product innovation and regulatory compliance.
Under the leadership of Chief Executive Officer Roland Diggelmann, Smith & Nephew continues to focus on expanding its digital surgery offerings, strengthening its biologics pipeline and pursuing targeted acquisitions to complement its core businesses. The company emphasizes long-term partnerships with hospitals and clinicians, investing in training programs, data-driven solutions and value-based healthcare initiatives to improve patient outcomes and optimize the total cost of care.
